Elucidation of the Interactions of an Anticancer Ruthenium Complex in Clinical Trials with Biomolecules Utilizing Capillary Electrophoresis Hyphenated to Inductively Coupled Plasma‐Mass Spectrometry. Short Communication
- 26 August 2008
- journal article
- research article
- Published by Wiley in Chemistry & Biodiversity
- Vol. 5 (8) , 1609-1614
Abstract
The application of capillary electrophoresis (CE) combined with highly sensitive inductively-coupled-plasma mass spectrometric (ICP-MS) detection allows the interactions of metal complexes with biomolecules to be characterized. This technique has been used to provide new insights into the mode of action of the ruthenium-based anticancer drug candidate indazolium [trans-tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019). While the compound binds rapidly and efficiently to serum proteins, especially albumin, its reactivity towards the model DNA compound 2′-deoxyguanosine 5′-monophosphate (5′-dGMP) is moderate.Keywords
This publication has 37 references indexed in Scilit:
- KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor PatientsChemistry & Biodiversity, 2008
- Probing the stability of serum protein–ruthenium(III) drug adducts in the presence of extracellular reductants using CEElectrophoresis, 2007
- Structure−Activity Relationships for NAMI-A-type Complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = Imidazole, Indazole, 1,2,4-Triazole, 4-Amino-1,2,4-triazole, and 1-Methyl-1,2,4-triazole): Aquation, Redox Properties, Protein Binding, and Antiproliferative ActivityJournal of Medicinal Chemistry, 2007
- From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)Journal of Inorganic Biochemistry, 2006
- Interactions of Antitumor Metallodrugs with Serum Proteins: Advances in Characterization Using Modern Analytical MethodologyChemical Reviews, 2006
- Metal-based antitumour drugs in the post genomic eraDalton Transactions, 2006
- Comparative binding of antitumor indazolium [trans-tetrachlorobis(1H-indazole)ruthenate(III)] to serum transport proteins assayed by capillary zone electrophoresisAnalytical Biochemistry, 2005
- A Phase I and Pharmacological Study with Imidazolium- trans- DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer AgentClinical Cancer Research, 2004
- Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopyJournal of Analytical Atomic Spectrometry, 2003
- Ruthenium metallopharmaceuticalsCoordination Chemistry Reviews, 2003